Farmacia
Faculté
University of Sfax
Sfax, TúnezPublications en collaboration avec des chercheurs de University of Sfax (23)
2024
-
Synthesis and Biological Evaluation of New Benzochromenopyrimidines for the Therapy of Colon and Lung Cancer
ChemistrySelect, Vol. 9, Núm. 2
2023
-
Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca2+ Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation
Molecules, Vol. 28, Núm. 1
-
Design, Synthesis, in Silico and Biological Evaluation of Novel 4-Aminopyrimidine-5-carbonitriles
ChemistrySelect, Vol. 8, Núm. 31
-
Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer’s Disease Treatment
International Journal of Molecular Sciences, Vol. 24, Núm. 11
2022
2021
-
Regioselective Synthesis of Novel [1,2,4]Triazolo[1,5-a]pyridine Derivatives
ChemistrySelect, Vol. 6, Núm. 5, pp. 945-950
-
Synthesis and Biological Assessment of PyrimidoTacrines as Promising Agents for Alzheimer's Disease Therapy
ChemistrySelect, Vol. 6, Núm. 37, pp. 9975-9980
-
Synthesis and Fluorescence of (E)-3-Aryl-2-(5-aryl-4H-1,2,4-triazol-3-yl) Acrylonitriles
ChemistrySelect, Vol. 6, Núm. 25, pp. 6360-6364
-
Tacrines as Therapeutic Agents for Alzheimer's Disease. V. Recent Developments
Chemical Record, Vol. 21, Núm. 1, pp. 162-174
2020
-
Triazolopyridopyrimidine: A new scaffold for dual-target small molecules for Alzheimer's disease therapy
Molecules, Vol. 25, Núm. 14
2019
-
Multi-target 1,4-dihydropyridines showing calcium channel blockade and antioxidant capacity for Alzheimer's disease therapy
Bioorganic Chemistry, Vol. 91
-
New Dual Small Molecules for Alzheimer's Disease Therapy Combining Histamine H3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition
Journal of Medicinal Chemistry, Vol. 62, Núm. 24, pp. 11416-11422
-
Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer’s disease therapy
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 34, Núm. 1, pp. 163-170
-
Synthesis of (±)-cis-1-Aryl-3-oxo-2,3-dihydro-1H-benzo[f]chromene-2-carbonitriles and (±)-trans-4-Aryl-2-oxo-3,4-dihydro-2H-benzo[h]chromene-3-carbonitriles
ChemistrySelect, Vol. 4, Núm. 44, pp. 12902-12905
2018
-
Synthesis, Biological Assessment and Molecular Modeling of Racemic QuinoPyranoTacrines for Alzheimer's Disease Therapy
ChemistrySelect, Vol. 3, Núm. 2, pp. 461-466
2017
-
Synthesis and biological assessment of racemic benzochromenopyrimidinetriones as promising agents for Alzheimer's disease therapy
Future Medicinal Chemistry, Vol. 9, Núm. 8, pp. 715-721
-
Tetrahydropyranodiquinolin-8-amines as new, non hepatotoxic, antioxidant, and acetylcholinesterase inhibitors for Alzheimer's disease therapy
European Journal of Medicinal Chemistry, Vol. 126, pp. 576-589
2016
-
Synthesis and Biological Assessment of Racemic Benzochromenopyrimidinimines as Antioxidant, Cholinesterase, and Aβ1−42Aggregation Inhibitors for Alzheimer's Disease Therapy
ChemMedChem, pp. 1318-1327
-
Synthesis and biological evaluation of benzochromenopyrimidinones as cholinesterase inhibitors and potent antioxidant, non-hepatotoxic agents for Alzheimer's disease
Molecules, Vol. 21, Núm. 5
2014
-
Isoxazolotacrines as non-toxic and selective butyrylcholinesterase inhibitors for Alzheimer's disease
Future Medicinal Chemistry, Vol. 6, Núm. 17, pp. 1883-1891